Evidence map›Paper›PMID 11564761›Full record

ArticleThe Journal of cell biology2001

The erbB2 gene is required for the development of terminally differentiated spinal cord oligodendrocytes.

S K Park, R Miller, I Krane, T Vartanian

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biased activation of the receptor tyrosine kinase HER2.Cellular and molecular life sciences : CMLS · 2023
    Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Increased numbers of oligodendrocyte lineage cells in the optic nerves of cerebroside sulfotransferase knockout mice.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2011
    Article
  18. Oligodendrocytes: biology and pathology.Acta neuropathologica · 2010
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

S K ParkDepartment of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
R Miller
I Krane
T Vartanian
Hadassah Medical Center · ILCase Western Reserve University · USHarvard University · US

Funding

PERIVENTRICULAR LEUKOMALACIA IN THE PREMATURE INFANTP01NS038475 · NINDS · CHILDREN'S HOSPITAL BOSTON · PI ROSENBERG, PAUL ALLEN · 2000 to 2009
$13.2M
Development of Oligodendrycytes in the Spinal CordR01NS030800 · NINDS · GEORGE WASHINGTON UNIVERSITY · PI MILLER, ROBERT H. · 1995 to 2018
$5.7M
NINDS NIH HHS NS02028NINDS NIH HHS NS30800NINDS NIH HHS P01 NS038475NINDS NIH HHS P01 NS38475-01NINDS NIH HHS R01 NS030800
6 · The paper itself

Abstract

Development of oligodendrocytes and the generation of myelin internodes within the spinal cord depends on regional signals derived from the notochord and axonally derived signals. Neuregulin 1 (NRG)-1, localized in the floor plate as well as in motor and sensory neurons, is necessary for normal oligodendrocyte development. Oligodendrocytes respond to NRGs by activating members of the erbB receptor tyrosine kinase family. Here, we show that erbB2 is not necessary for the early stages of oligodendrocyte precursor development, but is essential for proligodendroblasts to differentiate into galactosylcerebroside-positive (GalC+) oligodendrocytes. In the presence of erbB2, oligodendrocyte development is normal. In the absence of erbB2 (erbB2-/-), however, oligodendrocyte development is halted at the proligodendroblast stage with a >10-fold reduction in the number of GalC+ oligodendrocytes. ErbB2 appears to function in the transition of proligodendroblast to oligodendrocyte by transducing a terminal differentiation signal, since there is no evidence of increased oligodendrocyte death in the absence of erbB2. Furthermore, known survival signals for oligodendrocytes increase oligodendrocyte numbers in the presence of erbB2, but fail to do so in the absence of erbB2. Of the erbB2-/- oligodendrocytes that do differentiate, all fail to ensheath neurites. These data suggest that erbB2 is required for the terminal differentiation of oligodendrocytes and for development of myelin.

Indexed as

AnimalsAnimals, NewbornAstrocytesCell Culture TechniquesCell DeathCell DifferentiationCell LineageEmbryo, MammalianErb-b2 Receptor Tyrosine KinasesErbB ReceptorsGene Expression Regulation, DevelopmentalMiceMice, KnockoutMyelin SheathNeuregulinsNeuritesErb-b2 Receptor Tyrosine KinasesErbb4 protein, mouseErbB ReceptorsNeuregulinsReceptor, ErbB-3Receptor, ErbB-4

Identifiers

PMID11564761
PMCPMC2150828
OpenAlexW2137202834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.